Results 111 to 120 of about 1,842,584 (317)
Laparoscopic Middle Pancreatectomy under a Pancreatic Duct-Navigation Surgery [PDF]
Recent developments of diagnostic modalities have increased detection of many benign and low malignant pancreatic lesions, and then various minimally invasive surgeries and/or pancreatic function preserving surgeries have been devised for such lesions ...
Adachi, Tomohiko +5 more
core +1 more source
Combinations of small activating RNAs and small interfering RNAs were developed as personalized precision therapies that simultaneously activate tumor suppressors and silence oncogenes according to the molecular signatures of patient tumors. This combination strategy demonstrated superior anticancer efficacy, highlighting the promise of precision ...
Jing Wu +18 more
wiley +1 more source
Aoyun Hao, Changlei Li, Ruitao Sun, Bin Tan, Guanming Shao, Kun Li, Na Li, Weiyu Hu, Chao Qu, Jingyu Cao Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, People’s Republic of ...
Hao A +9 more
doaj
Role of common bile duct resection in T2 and T3 gallbladder cancer patients [PDF]
Backgrounds/Aims: Routine bile duct resection as part of the typical oncological resection for patients with advanced gallbladder cancer remains controversial with regard to, ultimately, curative value.
정재욱 +5 more
core +1 more source
A schematic model summarizing GNA15's mechanism in mediating macrophage M2 polarization and Gemcitabine resistance. ABSTRACT The complexity of pancreatic ductal adenocarcinoma (PDAC) progression, coupled with the lack of effective immunotherapy, underscores the imperative to deepen our understanding of its mechanisms and identify suitable immune ...
Weihui Guo +8 more
wiley +1 more source
Xuchen Zhao,1,* Jiale Xu,2,* Congzhong Hu,1,* Wei Xue,1 Zongyuan Che,1 Ruiqi Ling,1 Haoyang Chen,1 Yulin Feng,1 Xiaolong Li,1 Shaojian Mo,1 Yanzhang Tian1 1Department of Biliary and Pancreatic Surgery, The Third Hospital of Shanxi
Zhao X +10 more
doaj
The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma
Backgrounds/Aims: The aim of this study was to investigate the prognostic significance of neutrophyil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR), CRP and CA19-9 in patients were diagnosed with pancreatic ductal adenocarcinoma (PDAC) to ...
Aktekin, Ali +5 more
core +1 more source
LA‐LYTAC repurposes the cancer‐enriched amino acid transporter LAT1 as a lysosomal trafficking receptor for targeted membrane‐protein degradation. A single phenylalanine‐derived ligand, modularly linked to antibodies or small‐molecule binders, recruits PD‐L1, EGFR, or integrins to LAT1, triggering transporter‐mediated internalization, lysosomal ...
Liquan Zhu +12 more
wiley +1 more source
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy
Hesheng Lin,1,* Fulin Ran,2,* Jiayi Wu,3,* Chaoyue Huang,2,* Junyi Wu,3,* Chengyuan Liu,1 Xueyao Wang,4 Houxiang Ya,1 Kaiwen Jiang,1 Jing Gu,1 Maolin Yan,3 Shuqun Li1 1Department of Hepatobiliary and Pancreatic ...
Lin H +11 more
doaj
Background Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease, with over one-third of patients developing liver metastasis following neoadjuvant chemotherapy (NAC). This study aimed to investigate how the effect of chemotherapy on the
Bai’an Tao +11 more
doaj +1 more source

